Combined screening could boost COPD detection
Researchers from Japan say that the detection of chronic obstructive pulmonary disease could be enhanced by incorporating screening into existing lung cancer screening programs. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - September 7, 2013 Category: Cancer & Oncology Source Type: news
Prophylactic cranial irradiation beneficial in elderly SCLC patients
Prophylactic cranial irradiation improves survival in elderly patients with limited-stage small-cell lung cancer, analysis of US epidemiologic data indicates. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - September 6, 2013 Category: Cancer & Oncology Source Type: news
Assay aids ALK fusion detection in lung adenonocarcinoma
A fully automated immunochemistry assay is highly sensitive and specific for detecting anaplastic lymphoma kinase fusion in primary lung adenocarcinomas, Chinese researchers report. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - September 6, 2013 Category: Cancer & Oncology Source Type: news
CT screening proven effective for lung cancer
There is strong evidence to support the effectiveness of screening for lung cancer with low-dose computed tomography, a systematic review has found. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - September 5, 2013 Category: Cancer & Oncology Source Type: news
Chemotherapy best second-line option for EGFR wild-type NSCLC
Chemotherapy is more effective than erlotinib as second-line therapy in people with advanced non-small-cell lung cancer and wild-type epidermal growth factor receptor genotype, a randomized controlled trial has found. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - September 5, 2013 Category: Cancer & Oncology Source Type: news
Albumin-bound paclitaxel has favorable risk–benefit profile in NSCLC
Albumin-bound paclitaxel plus carboplatin is an effective and well-tolerated first-line treatment in patients with advanced non-small-cell lung cancer, irrespective of histology, study results show. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - August 29, 2013 Category: Cancer & Oncology Source Type: news
Tumor size key to visceral pleural invasion impact
Visceral pleural invasion significantly increases the risk for recurrence and reduces overall survival (OS) in patients with non-small-cell lung cancer, but only for those whose tumors are over 2 cm in diameter, research suggests. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - August 7, 2013 Category: Cancer & Oncology Source Type: news
NSCLC BRAF mutation characterized in the clinic
Clinical characteristics do not distinguish between non-small-cell lung cancer patients with and without BRAF mutations, report US scientists. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - August 7, 2013 Category: Cancer & Oncology Source Type: news
Afatinib effective in erlotinib/gefitinib-resistant NSCLC
Afatinib is effective when given to patients with non-small-cell lung cancer who have progressed during treatment with erlotinib and/or gefitinib, phase II trial results reveal. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - August 2, 2013 Category: Cancer & Oncology Source Type: news
Afatinib could become standard first-line option for metastatic NSCLC
Afatinib significantly prolongs progression-free survival in patients with metastatic lung adenocarcinoma and epidermal growth factor mutations, a phase III trial has found. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - August 2, 2013 Category: Cancer & Oncology Source Type: news
Major European study finds air pollution–lung cancer link
Exposure to ambient air pollution is associated with an increased risk for lung cancer, particularly adenocarcinoma, a large European cohort study indicates. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - July 30, 2013 Category: Cancer & Oncology Source Type: news
ROS1 rearrangement ‘specific for lung cancer in never-smokers’
Lung adenocarcinomas harboring genetic rearrangements of the receptor tyrosine kinase proto-oncogene ROS1 are more frequent in people who have never smoked than in smokers, a study by South Korean researchers shows. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - July 29, 2013 Category: Cancer & Oncology Source Type: news
Pemetrexed–bevacizumab effective maintenance therapy for NSCLC
Pemetrexed in combination with bevacizumab is superior to bevacizumab alone when given as continuation maintenance therapy in patients with advanced nonsquamous non-small-cell lung cancer, results of the AVAPERL trial show. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - July 29, 2013 Category: Cancer & Oncology Source Type: news
Pemetrexed maintenance therapy prolongs survival in nonsquamous NSCLC
Pemetrexed maintenance therapy offers a survival benefit over placebo and is well tolerated in patients with advanced nonsquamous non-small-cell lung cancer, final results of the PARAMOUNT trial show. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - July 26, 2013 Category: Cancer & Oncology Source Type: news
Intercalated regimen demonstrates first-line efficacy for advanced NSCLC
Administration of erlotinib in combination with chemotherapy is a viable first-line treatment strategy in patients with advanced non-small-cell lung cancer, results from FASTACT-2 suggest. (Source: MedWire News - Lung Cancer)
Source: MedWire News - Lung Cancer - July 26, 2013 Category: Cancer & Oncology Source Type: news
